Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that ...

Over the last year, a good number of insiders have significantly increased their holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). This is encouraging because it indicates that insiders are ...

The James Beard Foundation today announced its semifinalist nominees for 2025, officially kicking off restaurant awards season across the country. Widely known as the “Oscars” of the food world, the ...

Eating foods high in key nutrients, including iron, folic acid, and vitamin B12, and limiting alcohol may help increase your red blood cell count. Red blood cells are the most common cells in ...

Investing.com - Iovance Biotherapeutics (NASDAQ: IOVA) reported fourth quarter EPS of $-0.64, in line with the analyst estimate of $-0.64. Revenue for the quarter ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) active Investigational New Drug (IND) applications. These INDs ...

FDA places a clinical hold on Atara's EBVALLO and ATA3219 programs due to GMP compliance issues at a third-party facility. Atara to pause new participant enrollment; CAR-T programs may suspend in ...

After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline of T-cell immunotherapies. Atara on Tuesday announced that the FDA has ...

In 2009 a team of biophysicists led by Anthony A. Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, were studying specklelike structures called P ...

What’s new, aside from Bluesky also gaining swipeable videos, is the new video feeds. Bluesky has gained the most features, so let’s start there. Previously, videos on Bluesky used to work ...

The big US independent has quietly progressed its Salam-Patawali project offshore Sarawak over the past few years, and is now poised to begin a FEED competition with the winner likely being ...

In this article, we are going to take a look at where Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a ...